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Introduction
Once  considered  an  evolutionary  relic,  primary  cilia  (also 
called monocilia) are now believed to play essential roles in 
signaling pathways and organ development. They are singular 
extensions of the plasma membrane and contain an axoneme 
of nine peripheral microtubule doublets but no central pair of 
microtubules, and therefore are believed to be immotile in 
most circumstances. Stimulated not least by the identifica-
tion of most of the genes mutated in cystic kidney diseases, the 
primary cilium has become an intensely investigated organelle 
(Satir and Christensen, 2007). Mutations in the PKD1 (The Euro-
pean Polycystic Kidney Disease Consortium, 1994) and PKD2 
(Mochizuki et al., 1996) genes result in autosomal-dominant 
P
olycystin-2 (also called TRPP2), an integral mem-
brane protein mutated in patients with cystic kidney 
disease, is located in the primary cilium where it is 
thought to transmit mechanical stimuli into the cell interior. 
After studying a series of polycystin-2 deletion mutants we 
identified two amino acids in loop 4 that were essential for 
the trafficking of polycystin-2 to the somatic (nonciliary) 
plasma membrane. However, polycystin-2 mutant proteins 
in  which  these  two  residues  were  replaced  by  alanine 
were still sorted into the cilium, thus indicating that the 
trafficking routes to the somatic and ciliary plasma mem-
brane compartments are distinct. We also observed that 
the introduction of dominant-negative Sar1 mutant pro-
teins and treatment of cells with brefeldin A prevented the 
transport into the ciliary plasma membrane compartment, 
whereas metabolic labeling experiments, light microscopi-
cal imaging, and high-resolution electron microscopy re-
vealed  that  full-length  polycystin-2  did  not  traverse  the 
Golgi apparatus on its way to the cilium. These data argue 
that the transport of polycystin-2 to the ciliary and to the 
somatic plasma membrane compartments originates in   
a COPII-dependent fashion at the endoplasmic reticulum, 
that polycystin-2 reaches the cis side of the Golgi appara-
tus in either case, but that the trafficking to the somatic 
plasma  membrane  goes  through  the  Golgi  apparatus 
whereas transport vesicles to the cilium leave the Golgi 
apparatus at the cis compartment. Such an interpretation 
is supported by the finding that mycophenolic acid treat-
ment  resulted  in  the  colocalization  of  polycystin-2  with 
GM130, a marker of the cis-Golgi apparatus. Remark-
ably, we also observed that wild-type Smoothened, an   
integral membrane protein involved in hedgehog signaling 
that under resting conditions resides in the somatic plasma 
membrane, passed through the Golgi apparatus, but the 
M2 mutant of Smoothened, which is constitutively located 
in the ciliary but not in the somatic plasma membrane, 
does not. Finally, a dominant-negative form of Rab8a, a 
BBSome-associated  monomeric  GTPase,  prevented  the 
delivery of polycystin-2 to the primary cilium whereas a 
dominant-negative form of Rab23 showed no inhibitory 
effect, which is consistent with the view that the ciliary traf-
ficking of polycystin-2 is regulated by the BBSome.
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furthermore, it is not clear whether a membrane fusion machin-
ery is present in the cilium. A second hypothesis states that inte-
gral membrane proteins are first incorporated into the nonciliary 
plasma membrane and then move into the ciliary plasma mem-
brane. In a third model, integral membrane proteins reach a dock-
ing station at the base of the cilium where they are integrated into 
the ciliary plasma membrane and then move up and down the   
cilium. We now present evidence that polycystin-2 uses dis-
tinct pathways to reach the nonciliary and ciliary plasma mem-
brane compartments, thus indicating that the third model is 
correct. To emphasize the distinction between the two plasma 
membrane compartments in ciliated cells, we suggest calling the 
plasma membrane compartment lining the cell body the somatic 
plasma membrane.
Results
A motif adjoining the cytoplasmic side of 
the fourth membrane-spanning segment is 
critical for the insertion of polycystin-2 
into the somatic plasma membrane
It has been demonstrated that polycystin-2 mutant proteins   
terminating after amino acids 703 (Cai et al., 1999) and 741 
(Hanaoka et al., 2000) efficiently travel to the somatic plasma 
membrane, whereas the full-length polycystin-2 protein does 
not. In the course of another set of experiments we discovered 
that C-terminal truncation mutants of polycystin-2 with 582 
amino acids in length or longer were still incorporated into the 
plasma membrane, whereas truncation mutants with 547 amino 
acids and shorter were again retained in intracellular membrane 
compartments (Fig. 1, a and b). This finding indicated that   
polycystin-2 not only contained a retention signal for the ER in its   
C terminus but also an export signal embedded in the middle of 
the protein. When we went on to narrow down the amino acids 
responsible for the integration of polycystin-2 into the plasma 
membrane by making additional truncation mutants we arrived at 
the result that polycystin-2 (1–576) reached the plasma membrane 
but polycystin-2 (1–573) is unable to do so (Fig. 1, c and d).
A comparison of the human, murine, rat, canine, bovine, 
and  chicken  polycystin-2  sequences  showed  that  the  region 
from amino acids 572 to 577 was highly conserved between the 
different species (Fig. 2 a). This encouraged us to exchange   
single amino acids in the context of the polycystin-2 (1–703) 
mutant. The polycystin-2 (1–703) mutant has been well charac-
terized  in  several  publications.  It  escapes  from  the  ER  and 
reaches both the somatic and the ciliary plasma membrane com-
partments (Cai et al., 1999; Gallagher et al., 2006) where it can 
still act as a cation channel, although with characteristics differ-
ent from the full-length protein (Koulen et al., 2002). Because 
truncations in themselves may disturb the local protein struc-
ture, we felt that amino acid substitutions were more informa-
tive. Both the substitution of amino acids KLF (572–574) and 
of amino acids KFI (575–577) by alanines maintained the sen-
sitivity of the mutant proteins to endoglycosidase H, thus indi-
cating that the two substitution mutants were retained in the   
ER (Fig. 2 b). This finding was corroborated by a cell surface 
biotinylation assay that showed a markedly reduced biotinylation 
polycystic  kidney  disease.  Orthologues  of  polycystin-1  and 
polycystin-2, the proteins encoded by the PKD1 and PKD2 
genes, were first localized to the ciliated endings of sensory 
neurons in Caenorhabditis elegans (Barr and Sternberg, 1999)   
before they were detected in primary cilia of mammalian cells 
(Pazour et al., 2002; Yoder et al., 2002). Meanwhile, a plethora 
of cyst-associated proteins has been detected in primary cilia, 
among them IFT88/Polaris (the protein mutated in a murine 
model  of  polycystic  kidney  disease),  fibrocystin/polyductin 
(mutated in patients suffering from autosomal-recessive poly-
cystic kidney disease), most of the nephrocystins (mutated in 
patients  suffering  from  nephronophthisis),  the  BBS  proteins 
(mutated in patients suffering from Bardet-Biedl syndrome), 
OFD1  (a  protein  mutated  in  patients  with  oral-facial-digital 
syndrome, which is also associated with polycystic kidney dis-
ease), and cystin (mutated in a spontaneous model of polycystic 
kidney disease in the mouse; Yoder, 2007). No consensus has 
yet emerged for the role of primary cilia in mammalian cells 
(Witzgall, 2005a). Not only have they been attributed a chemo- 
and mechanosensory role, but they are also felt to be essential 
for signal transduction in the hedgehog, Wnt, and planar cell 
polarity pathways (Bisgrove and Yost, 2006; Singla and Reiter, 
2006; Wang and Nathans, 2007).
The intracellular location of polycystin-2 has been dis-
cussed controversially. Whereas some groups favor a retention 
of polycystin-2 in the ER, others have argued for its trafficking 
to the plasma membrane (Witzgall, 2005b). The initial charac-
terization has resulted in the identification of a retention signal 
for the ER in the C terminus of polycystin-2, and indeed mutant 
proteins lacking most of the C terminus have been shown to   
escape from the ER (Cai et al., 1999; Hanaoka et al., 2000). 
Further analysis of the C terminus has yielded more evidence 
for the importance of this portion of polycystin-2. Using a   
two-hybrid screen with the C terminus as a bait, we were able   
to isolate PIGEA-14 (also called Chibby), a novel protein which   
in addition interacts with the Golgi matrix component GM130 
(Hidaka et al., 2004) and which may also be involved in -catenin 
signaling (Takemaru et al., 2003; Li et al., 2007). A stretch of 
acidic amino acids in the C terminus of polycystin-2 mediates 
the interaction with PACS-1 and PACS-2 (Köttgen et al., 2005). 
The association between polycystin-2 and the PACS proteins is 
regulated through the phosphorylation of a serine residue at   
position 812 of polycystin-2 (Köttgen et al., 2005), but there is 
conflicting evidence whether the phosphorylation status is im-
portant for the retention of polycystin-2 in the ER (Cai et al., 2004; 
Köttgen et al., 2005).
It is generally agreed upon that polycystin-2 reaches the 
primary cilium (Pazour et al., 2002; Yoder et al., 2002), but how 
it gets there is unknown. There are essentially three alternative 
routes by which integral membrane proteins may become inte-
grated into the ciliary plasma membrane (Witzgall, 2005b). At 
the current state of knowledge the least likely route is the trans-
port of vesicles into the primary cilium via intraflagellar transport 
and their subsequent fusion with the ciliary plasma membrane 
anywhere along the length of the cilium. Although contrary   
reports have been published (Jensen et al., 2004), it is believed 
that the cilium does not contain vesicles (Kozminski et al., 1993); 633 Intracellular trafficking of polycystin-2 • Hoffmeister et al.
KFI575-577AAA, whereas the other mutants were transported 
to the same extent to the somatic plasma membrane as the non-
mutated polycystin-2 (1–703) construct and the plasma membrane 
protein Na
+/K
+-ATPase, which we used as a control. No full-
length polycystin-2 was detected at the cell surface (Fig. 2 e).
Evidence for only partially overlapping 
sorting pathways of polycystin-2 into the 
somatic and ciliary plasma membrane
To obtain a dynamic picture of the intracellular movements of 
polycystin-2, pulse-chase experiments were performed in HeLa 
cells (another nonciliated cell line) and in LLC-PK1 cells. By 
radioactively labeling the cells for a short period of 5 min we 
were able to follow the fate of newly synthesized polycystin-2 
for up to 24 h. Except for the appearance of a slower migrating 
band after 4 h, no post-translational modifications were ob-
served for the full-length polycystin-2 protein over this period 
in both cell lines; furthermore, distinct bands were present even 
after a chase of 24 h (Fig. 3 a). Because the top band dis-
appeared after a digest with calf intestinal phosphatase (not de-
picted),  this  shows  that  full-length  polycystin-2  becomes 
phosphorylated soon after it is synthesized. Immunoprecipitated 
polycystin-2 was also subjected to treatment with PNGase F and 
endoglycosidase H. Whereas PNGase F removes any N-linked 
sugar residues regardless of their modification and therefore   
can be used to determine whether a protein is N-glycosylated, 
endoglycosidase H will only remove the sugar residues if a   
glycoprotein has not reached the mid-Golgi compartment. The 
digestion with both enzymes yielded faster migrating protein 
species (Fig. 3, b and c) and confirms that full-length polycystin-2 
does not reach the mid-Golgi compartment (Cai et al., 1999; 
Hidaka et al., 2004). The pulse-chase results therefore strongly 
argue against the possibility that full-length polycystin-2 moves 
rapidly through the Golgi apparatus and is then quickly de-
graded before reaching the plasma membrane. More complex 
glycosylation patterns were apparent in the case of the polycystin-2 
(1–703) protein, where a smear of a higher molecular weight 
was seen after 2 h in addition to two lower bands (Fig. 3 d). 
The smear was transformed to a lower molecular weight after a 
digest with PNGase F but was still present after a digest with 
endoglycosidase H (although its mobility increased a little), and 
it therefore represents a form that has moved to the mid-Golgi 
apparatus and beyond (Fig. 3, e and f). The two lower bands, 
however, were reduced to a single faster-migrating species both 
by PNGase F and endoglycosidase H. They therefore represent 
a pool of protein that has not reached the mid-Golgi compart-
ment even over a period of 24 h.
Because the ciliary plasma membrane only constitutes a 
small portion of the total plasma membrane area, biochemical 
assays such as biotinylation of intact cells and pulse-chase ex-
periments may not indicate whether an integral membrane protein 
is indeed absent from the ciliary plasma membrane. We there-
fore transiently transfected LLC-PK1 cells with expression con-
structs for the HA epitope–tagged mutant polycystin-2 proteins 
and stained them with antibodies against the HA epitope and 
acetylated tubulin. Somewhat unexpectedly, the cilia contained 
even those mutant proteins that no longer reached the somatic 
of the two polycystin-2 substitution mutants in COS-7 cells 
(a nonciliated cell line) and in LLC-PK1 cells (a ciliated cell line; 
Fig. 2, c and d). Finally, single amino acid substitutions were 
assayed in COS-7 cells, which demonstrated that the K572A 
and F576A mutants reached the somatic plasma membrane as 
inefficiently as the triple-alanine mutants KLF572-574AAA and 
Figure 1.  Evidence for an export motif in polycystin-2. COS-7 cells were 
transiently transfected with expression plasmids for the polycystin-2 mutant 
proteins indicated. 2 d later the cells were stained with an antibody di-
rected against an extracellular domain (loop 1) of polycystin-2 (red) in the 
presence and absence of the detergent Triton X-100. Only when the mutant 
proteins reached the plasma membrane could a signal be detected in the 
absence of Triton X-100. Nuclei were counterstained with Hoechst 33258 
(blue) to demonstrate the presence of cells. Bar, 100 µm.JCB • VOLUME 192 • NUMBER 4 • 2011   634
in the pulse-chase experiments suggested an early branching of 
the two pathways, i.e., at the level of the ER, the ER-Golgi inter-
mediate compartment, or at the cis-Golgi apparatus.
Therefore, we transiently transfected an expression plas-
mid for polycystin-2 (1–703) together with expression plasmids 
plasma membrane (Fig. 4). This indicated that the trafficking 
pathways of polycystin-2 into the somatic and ciliary plasma 
membrane were different. However, it left open the question of 
where the two routes diverged. The fact that the full-length 
polycystin-2 protein was always completely sensitive to Endo H 
Figure 2.  Endoglycosidase H sensitivity and cell surface biotinylation of mutated polycystin-2 proteins. (a) Sequence comparison of polycystin-2 from 
various species. Shown are amino acids 569–580 of the human protein; the last three amino acids of the presumptive fourth membrane-spanning seg-
ment (TMD4) are highlighted in gray. (b) Endoglycosidase Hf (Endo H) assay of HA epitope–tagged full-length polycystin-2 (PC2, HA) and of polycystin-2 
(1–703) without additional mutation (No mut.) and with alanine substitutions at positions 572–574 and 575–577. The full-length polycystin-2 protein and 
the triple-alanine substitution mutants are fully sensitive to treatment with Endo H, but the polycystin-2 (1–703) protein without additional mutations is not 
(asterisk indicates the resistant band). The band indicated by the arrow probably represents full-length polycystin-2 that did not enter the gel. (c–e) Surface 
biotinylation of COS-7 (c and e) and LLC-PK1 cells (d) transiently transfected with expression plasmids for the indicated proteins. The 1 subunit of the 
Na
+/K
+-ATPase served as a control for efficient biotinylation of plasma membrane proteins. When proteins were (mostly) retained in intracellular membrane 
compartments, no signal or only a weak signal was detected after precipitation with NeutrAvidin beads. The arrow in d indicates a nonspecific band. 
Molecular masses (in kD) are indicated on the left of panels b–e. L, whole-cell lysate; B, proteins precipitated with NeutrAvidin beads; S, proteins left in the 
supernatant after precipitation with NeutrAvidin beads.635 Intracellular trafficking of polycystin-2 • Hoffmeister et al.
decreased presence of the polycystin-2 (1–703) protein in the   
cilium (Fig. 5, a–h). Polycystin-2 (1–703) was absent from the 
cilium in all of the cells synthesizing the H79G mutant (posi-
tive cilia: 0/11) and in 10 out of 14 cells synthesizing the T39N   
for the Sar1 mutant proteins T39N and H79G, which disrupt the 
COPII-dependent  budding  of  vesicles  from  the  ER  (Aridor   
et al., 1995), into LLC-PK1 cells. Both the GDP-locked T39N 
and the GTP-locked H79G Sar1 mutant resulted in a strongly 
Figure 3.  Pulse-chase labeling of full-length polycystin-2 and polycystin-2 (1–703). Stably transfected HeLa and LLC-PK1 cells inducibly producing HA   
epitope–tagged full-length polycystin-2 (a–c) and polycystin-2 (1–703; d–f) proteins were metabolically labeled with 
35S-methionine/cysteine. The HA-tagged 
proteins were immunoprecipitated with an anti-HA epitope antibody, digested with PNGase F and endoglycosidase H (Endo H) when indicated, run on a 
polyacrylamide gel, and visualized by autoradiography. (a–c) The full-length polycystin-2 can be digested with both glycosidases at any time point after the 
pulse. Because the top band (filled arrowhead) disappeared after a digest with calf intestinal phosphatase (not depicted), it represents a phosphorylated 
form of polycystin-2. (d–f) The truncated polycystin-2 protein migrated as a smear (large arrow) 2 h after the pulse. The smear was resistant to endo-
glycosidase H and therefore probably represents protein that has progressed beyond the cis-Golgi apparatus. Because both bottom bands (filled and open 
arrowhead) collapsed into one faster-migrating band (small arrow) after endoglycosidase H treatment, they represent a pool of truncated polycystin-2 that 
did not reach the mid-Golgi apparatus. Molecular masses (in kD) are indicated on the left of each panel.JCB • VOLUME 192 • NUMBER 4 • 2011   636
mutant (positive cilia: 4/14). This argued that trafficking into 
the cilium originated with a COPII-dependent transport from 
the ER. Treatment of LLC-PK1 cells with the Golgi-disrupting 
agent brefeldin A also prevented both the incorporation of the 
full-length polycystin-2 and the polycystin-2 (1–703) mutant 
protein into primary cilia (Fig. 5, i–p; Fig. S1), which demon-
strates that polycystin-2 has to reach the Golgi apparatus before 
being routed into the cilium (although it does not move through 
it as indicated by the pulse-chase experiments and the experi-
ments described in the following paragraphs).
In another set of experiments we resorted to light micro-
scopic imaging to provide a dynamic picture of the intracellular 
trafficking of polycystin-2. LLC-PK1 cells were stably trans-
fected with expression plasmids for fusion proteins between 
ECFP and N-acetylgalactosaminyltransferase-2, a marker for 
all compartments of the Golgi apparatus (Röttger et al., 1998; 
White et al., 2001), and TGN38, a marker of the trans-Golgi 
network  (McNamara  et  al.,  2004),  respectively.  Subsequent 
transient transfections were performed to synthesize EGFP   
fusion proteins with full-length polycystin-2 and polycystin-2 
(1–703), respectively, in those cells. Insertion of EGFP into the 
N terminus of full-length polycystin-2 (after amino acid 157), 
and fusion of EGFP to the C terminus of polycystin-2 (1–703) 
still permitted the transport of either polycystin-2 construct into 
the cilium (Fig. 6, a and j). 3–4 d after transfection, the cells 
were incubated for 5 h at 15°C to arrest newly synthesized   
protein between the ER and the Golgi apparatus. Upon return-
ing the cells to 37°C the further transport of the polycystin-2   
proteins was observed. Whereas polycystin-2 (1–703) rapidly 
reached the Golgi apparatus (Fig. 6, k and l) and the trans-Golgi 
network (Fig. 6, m and n), we did not detect full-length poly-
cystin-2 in these compartments (Fig. 6, b–e; Video 1). Identi-
cal experiments were performed with the (KFI575-577AAA) 
mutants of full-length and truncated polycystin-2 in order to 
investigate the intracellular route of polycystin-2 mutant pro-
teins that no longer reached the somatic plasma membrane but 
only the primary cilium. In neither case did we observe traffick-
ing through the Golgi apparatus and the trans-Golgi network 
(Fig. 6, f–i and o–r).
Further  evidence  for  different  trafficking  pathways  of 
polycystin-2 into the somatic and the ciliary plasma membrane 
was sought by electron microscopy. We used the same EGFP 
fusion proteins described in the previous paragraph but inserted 
an additional 12–amino acid tetracysteine motif. The tetracys-
teine motif contains four cysteine residues that are able to bind 
the biarsenical fluorophore ReAsH. ReAsH in turn is used to 
photoconvert diaminobenzidine into an electron-dense product 
that can be visualized in the electron microscope. In contrast to 
immunogold labeling where the gold particles are often distrib-
uted in a somewhat scattered fashion around the target and the 
ultrastructural details are poorly preserved, the ReAsH tech-
nique has the big advantage of a well-maintained ultrastructure 
paired with an extremely high resolution because the diamino-
benzidine precipitates form right at the ReAsH-labeled protein 
(Gaietta et al., 2002). Transiently transfected cells expressing 
the respective expression constructs were identified through the 
EGFP portion of the fusion proteins. After ReAsH labeling the 
Figure 4.  Ciliary trafficking of polycystin-2 mutant proteins. LLC-PK1 cells 
were transiently transfected with expression plasmids for HA epitope–tagged 
polycystin-2 (1–703) proteins without and with the indicated alanine sub-
stitutions. 3–4 d after transfection, cells were double stained for the HA 
epitope and for the primary cilia marker acetylated tubulin. Primary cilia 
are indicated by arrows. Bar, 15 µm.637 Intracellular trafficking of polycystin-2 • Hoffmeister et al.
cells were fixed, photoconverted, embedded in plastic, and seri-
ally sectioned. When we studied the Golgi region of the cells 
that synthesized polycystin-2 (1–703) it was obvious that the 
Golgi apparatus was stained by the diaminobenzidine precipi-
tate (Fig. 7 b). In cells synthesizing full-length polycystin-2 
(Fig. 7 a), however, the Golgi apparatus was not labeled, which 
again supported the interpretation that the full-length protein 
did not move through the Golgi apparatus on its way to the   
primary cilium. EGFP-negative control cells also showed no   
diaminobenzidine precipitate at the Golgi apparatus, which em-
phasized the specificity of the technique (Fig. 7 c). One possible 
prediction of the experiments with brefeldin A would have been 
that polycystin-2 is detected in the cis compartment of the Golgi 
apparatus. However, if most of the polycystin-2 protein is rap-
idly transported back to the ER, and if that portion of polycystin-2, 
which moves further on to the primary cilium, either quickly 
moves through the cis-Golgi apparatus or only briefly touches 
the cis-Golgi apparatus and is then quickly diverted, polycystin-2 
will not reach high enough levels to be detected in this compart-
ment. In an attempt to increase the levels of polycystin-2 in the 
cis-Golgi apparatus we treated cells with mycophenolic acid, a 
strong inhibitor of inosine 5-monophosphate dehydrogenase 
(IMPDH) (Franklin and Cook, 1969). Because this enzyme cat-
alyzes the rate-limiting step in the synthesis of GTP, and because   
G proteins play essential roles in various vesicular trafficking 
pathways, we reasoned that mycophenolic acid treatment may 
lead to higher polycystin-2 levels in the cis-Golgi apparatus.   
Indeed, we were able to observe vesicular structures in which 
polycystin-2 colocalized with GM130, a marker of the cis-Golgi 
apparatus (Nakamura et al., 1995), upon treatment with myco-
phenolic acid (Fig. S2).
We wanted to find out whether the trafficking route of 
polycystin-2 to the primary cilium was exceptional or whether 
similar  observations  could  also  be  made  for  other  proteins. 
Smoothened, an integral membrane protein involved in hedge-
hog signaling, is located at the somatic plasma membrane in the 
absence of hedgehog and moves into the cilium in its presence 
(Corbit et al., 2005; Milenkovic et al., 2009). The constitutively 
active M2 mutant of Smoothened, which is mutated in patients 
with basal cell carcinoma (Xie et al., 1998), however, is con-
stantly located in the primary cilium (Corbit et al., 2005).   
Fusion proteins between EYFP and wild-type and the M2 mu-
tant of Smoothened, respectively, were subjected to the same 
Figure 5.  The ciliary trafficking of polycystin-2 requires COPII and an 
intact Golgi apparatus. (a–h) LLC-PK1 cells were transiently transfected with 
8 µg of an expression plasmid for ECFP (a–d) or a fusion protein between 
ECFP and the dominant-negative Sar1 (H79G) protein (e–h) and with 6 µg 
of an expression plasmid for HA epitope–tagged polycystin-2 (1–703). 
3 d after transfection, the cells were either stained for the HA epitope or 
double-stained for the HA epitope and acetylated tubulin. Whereas ECFP 
had no effect on the ciliary location of the truncated polycystin-2 protein, 
the ECFP-Sar1 (H79G) fusion protein prevented the trafficking of the trun-
cated polycystin-2 into primary cilia. a/b, c/d, e/f, and g/h represent 
corresponding  panels.  (i–p)  LtA-2,22  cells  were  stably  transfected  with 
expression plasmids for HA epitope–tagged full-length and polycystin-2 
(1–703) proteins, and treated with brefeldin A (+BFA; i, k, m, and o) or 
with the solvent methanol (BFA; j, l, n, and p). Double staining for the HA 
epitope and acetylated tubulin revealed that in the presence of brefeldin A 
the truncated and the full-length polycystin-2 protein no longer reached pri-
mary cilia. i/k, j/l, m/o, and n/p represent corresponding panels. Primary 
cilia are indicated by arrows. Bars: (a–h) 25 µm, (i–p) 10 µm.
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Figure 6.  Trafficking of full-length polycystin-2 and polycystin-2 (1–703) with respect to the Golgi apparatus and the trans-Golgi network. (a and j) Immuno-
staining for acetylated tubulin (red) demonstrates that EGFP fusion proteins with full-length polycystin-2 (PC (fl)) and truncated polycystin-2 (PC2 (1–703)) 
still enter the primary cilium. (b–e and k–n) LLC-PK1 cells stably synthesizing ECFP fusion proteins with N-acetylgalactosaminyltransferase-2 (T2) and TGN38 
(shown in red for better visibility) were transiently transfected with expression plasmids coding for an EGFP fusion protein with the respective polycystin-2 639 Intracellular trafficking of polycystin-2 • Hoffmeister et al.
dominant-negative Rab8a and Rab23 mutant proteins. Whereas 
the truncated polycystin-2 protein was only very rarely detected 
in  primary  cilia  after  microinjection  of  the  Rab8a  construct 
(Fig. 9; positive cilia: 3/32, i.e., 9.4%), microinjection of the   
expression plasmid for the dominant-negative Rab23 protein 
(positive cilia: 26/34, i.e., 76.5%) and for CFP (positive cilia: 
52/60, i.e., 86.7%) had no effect in most cells (not depicted).   
Therefore, the trafficking of polycystin-2 into primary cilia de-
pends on Rab8a but obviously not on Rab23.
temperature shift protocol as full-length and truncated poly-
cystin-2. Wild-type Smoothened moved through the Golgi appara-
tus and the trans-Golgi network on its way to the somatic plasma 
membrane upon release from the 15°C block (Fig. 8, a–d), but 
we found no evidence that the M2 mutant used this pathway on 
its way to the primary cilium (Fig. 8, e–h).
Rab8a is essential for the trafficking of 
polycystin-2 into the primary cilium
We have previously identified PIGEA-14 (also called Chibby) 
as a protein interacting with the C terminus of polycystin-2   
(Hidaka et al., 2004). PIGEA-14 also interacts with GM130, 
and the synthesis of (high levels of) PIGEA-14 and polycystin-2 
leads to a striking redistribution of both proteins into the trans-
Golgi network (Hidaka et al., 2004). Furthermore, the germline 
inactivation of the gene encoding PIGEA-14 causes morphological 
and functional defects of kinocilia in the airways (Voronina et al., 
2009). This encouraged us to investigate the role of PIGEA-14   
in the trafficking of polycystin-2 to the primary cilium. The   
human PIGEA-14 protein is 126 amino acids long and contains 
a putative coiled-coil domain between amino acids 69 and 109, 
which is necessary for the interaction with both polycystin-2 
and GM130 (Hidaka et al., 2004). We therefore speculated   
that PIGEA-14 deletion mutants would interfere with the func-
tion of the endogenous PIGEA-14 protein. Expression constructs 
encoding fusion proteins between ECFP and two different por-
tions of PIGEA-14 (amino acids 1–64 and amino acids 65–126, 
respectively) were transiently transfected and microinjected into 
stably transfected LLC-PK1 cells inducibly producing HA   
epitope–tagged full-length polycystin-2 and polycystin-2 (1–703). 
A statistically significant effect, however, was only found for 
the trafficking of polycystin-2 (1–703) upon the transient trans-
fection of PIGEA-14 (65–126) (Fig. S3 a), and not for the other 
conditions tested (Fig. S3, a and b). This negative result could 
not be explained by the ineffectiveness of the PIGEA-14 con-
structs because both constructs led to a decrease in the number 
of cells elaborating cilia (Fig. S3 c).
Recent publications have provided evidence that mono-
meric GTPases of the Rab family, in particular Rab8a, Rab17, 
and Rab23 (Nachury et al., 2007; Yoshimura et al., 2007), and a 
set of proteins mutated in patients with Bardet-Biedl syndrome 
(the BBSome; Nachury et al., 2007), regulate the growth of 
cilia. Because Rab proteins are involved in intracellular vesicle 
trafficking and because the extension of cilia requires the 
incorporation of new membrane material, we considered them 
promising candidates to mediate the entry of transport vesicles 
containing polycystin-2 into the ciliary membrane. Stably trans-
fected LLC-PK1 cells synthesizing a fusion protein between 
EGFP and polycystin-2 (1–703) were grown to confluency in 
order to make sure that most cells would form primary cilia. 
Then  they  were  microinjected  with  expression  plasmids  for 
proteins. 3–4 d later, the cells were incubated for 5 h at 15°C before being incubated at 37°C. Immediately before (0 min) and 40 min after (40 min) shift-
ing the cells from 15°C to 37°C, the cells were fixed and visualized in a confocal laser scanning microscope. No overlapping signal can be seen between 
full-length polycystin-2 and the two marker proteins (b–e), whereas a good overlap was observed for the truncated polycystin-2 protein (k–n). (f–I and o–r) 
Analogous experiments were performed for the (KFI575-577AAA) mutants of full-length polycystin-2 and polycystin-2 (1–703). For neither mutant protein 
were we able to detect a colocalization with N-acetylgalactosaminyltransferase-2 and TGN38. Bar, 5 µm.
 
Figure 7.  Ultrastructural localization of full-length polycystin-2 and poly-
cystin-2 (1–703). COS-7 cells were transiently transfected with expression 
plasmids for full-length polycystin-2 (a) and polycystin-2 (1–703) (b and c) 
fused with EGFP and the tetracysteine motif. (a and b) Cells with EGFP 
fluorescence. Asterisks in b indicate Golgi cisternae with an osmiophilic 
diaminobenzidine precipitate in a cell producing the truncated polycystin-
2 protein. No such precipitate can be seen in a cell producing full-length 
polycystin-2. (c) A cell without EGFP fluorescence served to demonstrate 
background staining. The arrows in a and c point to clathrin-coated bud-
ding vesicles marking the trans-Golgi network. Bar, 200 nm.JCB • VOLUME 192 • NUMBER 4 • 2011   640
proteins such as the type 6 serotonin receptor (Brailov et al., 
2000) and the type 3 somatostatin receptor (Händel et al., 1999) 
are restricted to the ciliary plasma membrane at least in some 
cell types. Second, the C terminus is not necessary for polycystin-2 
to be sorted into the primary cilium. Third, the finding that   
the truncated polycystin-2 protein reaches both plasma mem-
brane compartments could be explained by the promiscuous 
trafficking of the mutant protein, but it also leaves open the pos-
sibility  that  the  trafficking  routes  to  the  somatic  and  ciliary 
plasma membranes are distinct. Our current study supports the 
latter model because the substitution of K572 and of F576 by 
alanines prevented the insertion of the truncated polycystin-2 
protein into the somatic but not into the ciliary plasma mem-
brane. There is precedent for the importance of a lysine residue 
in the intracellular linker region between the fourth and fifth 
membrane-spanning domain as an export motif of cation chan-
nels. The K
+ channels IK1 and SK3, which are usually inte-
grated into the somatic plasma membrane, are both retained in 
intracellular membrane compartments upon the mutation of the 
respective lysine residues to alanine (Jones et al., 2005). We are 
not aware, however, of any publications that have reported on 
Discussion
Different scenarios have been suggested regarding the subcellu-
lar location of polycystin-2 (Witzgall, 2005b). One says that 
polycystin-2 resides in the ER and in the ciliary plasma mem-
brane, another argues for the constitutive location of polycystin-2 
in the somatic and ciliary plasma membrane compartments, 
and a third poses that the exit of polycystin-2 from the ER to the 
somatic plasma membrane depends on the presence of other 
proteins such as polycystin-1 (Witzgall, 2005b). Whichever of 
these models will turn out to be correct, one crucial question to be 
answered concerns the mechanism by which polycystin-2 and 
other integral membrane proteins traffic to the primary cilium.
At least in the cellular systems used by us, the full-length 
polycystin-2 protein reaches the ciliary, but not the somatic, 
plasma membrane, whereas the truncated polycystin-2 protein 
lacking virtually the complete C terminus is integrated into both 
plasma membrane compartments. Several conclusions can be 
drawn from these observations. First, a barrier has to exist that 
separates the ciliary from the somatic plasma membrane be-
cause not only the full-length polycystin-2 protein but also other 
Figure 8.  Trafficking of wild-type Smoothened and the M2 mutant of Smoothened. LLC-PK1 cells stably synthesizing ECFP fusion proteins with N-acetyl-
galactosaminyltransferase-2 (T2) and TGN38 (shown in red for better visibility) were transiently transfected with expression plasmids coding for an EYFP 
fusion protein with the respective Smoothened proteins (shown in green for better visibility). 3–4 d later, the cells were incubated for 5 h at 15°C before 
being incubated at 37°C. Immediately before (0 min) as well as 15 min (15 min) and 40 min (40 min) after shifting the cells from 15°C to 37°C, the cells 
were fixed and visualized in a confocal laser scanning microscope. Overlapping signals were seen between wild-type Smoothened and the two marker 
proteins (a–d), whereas no overlap was observed for the M2 mutant of Smoothened (e–h). Bar, 5 µm.641 Intracellular trafficking of polycystin-2 • Hoffmeister et al.
apparatus found. However, our pharmacological experiments 
with brefeldin A indicate that an intact Golgi apparatus is neces-
sary for polycystin-2 to reach the cilium. Because except for 
very few examples (Saunders et al., 1985) proteins only become 
resistant to Endo H once they reach the mid-Golgi compart-
ment,  we  argue  that  full-length  polycystin-2  reaches  the  cis 
compartment of the Golgi apparatus in order to move to the cili-
ary plasma membrane but that the majority of it is returned to 
the ER. We admit, however, that the ciliary plasma membrane 
represents only a small portion of the total plasma membrane 
and that Endo H assays of proteins obtained from whole-cell 
extracts (just as the biotinylation of intact cells) may not be sen-
sitive enough to detect ciliary membrane proteins. Although it is 
formally possible that the full-length polycystin-2 protein is 
first transported through the Golgi apparatus and only a small 
portion of it moves on to the primary cilium whereas the major-
ity of it is degraded, the stability of polycystin-2 as shown in the 
pulse-chase experiments does not support this interpretation. 
Our light and electron microscopic data also argue against the 
idea that full-length polycystin-2 moves through the Golgi ap-
paratus in order to reach the cilium. Therefore, the interaction 
of polycystin-2 with the cis compartment of the Golgi appa-
ratus, which appears as a necessary intermediate step on the   
way to the cilium as indicated by our Brefeldin experiments,   
is probably only transient. The inhibition experiments with 
mycophenolic acid in which we were able to colocalize poly-
cystin-2 with GM130 at the cis-Golgi compartment favor such 
a model. We think that the lower intracellular GTP levels upon 
the significance of a single phenylalanine residue for the export 
of an integral membrane protein out of the ER. Di-phenylalanine 
and phenylalanine-tyrosine motifs such as that present in the   
C terminus of ERGIC-53 have been demonstrated to interact 
with COPII (Kappeler et al., 1997), but the single phenylalanine 
residue and its position in the middle of the protein make that 
unlikely for polycystin-2. Preliminary experiments in which the 
KLFKFI motif of polycystin-2 was inserted into the potassium 
channel Kir 2.1, which like polycystin-2 contains six mem-
brane-spanning domains, indicate that it was not able to substi-
tute for the ER and Golgi export signals of Kir 2.1 (unpublished 
data). We also tested whether the KLFKFI domain was func-
tional in the asialoglycoprotein receptor subunit H1, a protein 
with a single membrane-spanning domain, but again found no 
evidence that it was able to substitute for the endogenous Golgi 
export signal (unpublished data). This argues that the KLFKFI 
domain exerts its effect in a context-specific fashion.
Our data argue strongly that the route of integral mem-
brane proteins such as polycystin-2 to the primary cilium does 
not occur via the somatic plasma membrane but rather directly to 
the cilium. Previous (more indirect) evidence supports such a 
conclusion. A RVxP motif in the N terminus of polycystin-2 is 
necessary to target the truncated polycystin-2 protein to the cil-
ium. This motif was also sufficient to sort the transferrin recep-
tor, a somatic plasma membrane protein, into the cilium (Geng 
et al., 2006). Because no components of the vesicle fusion ma-
chinery such as SNARE proteins have been described in the cil-
ium, it is difficult to imagine how integral membrane proteins 
can be delivered to the ciliary plasma membrane even if trans-
port vesicles entered the cilium. Indeed, ultrastructural investi-
gations have demonstrated the appearance of ciliary components 
at the base of the cilium but not at the somatic plasma membrane 
(Bouck, 1971; Deretic and Papermaster, 1991). Potential regula-
tory proteins such as the monomeric G protein Rab8a and vari-
ous Bardet-Biedl proteins (the “BBSome”) are located at the 
basal body and are essential for ciliogenesis (Nachury et al., 
2007; Yoshimura et al., 2007). Our results provide evidence that 
Rab8a regulates the trafficking of polycystin-2 to the cilium.   
In addition to Rab8a, Rab17 and Rab23 have been found necessary 
for the elaboration of primary cilia (Yoshimura et al., 2007), but 
only Rab8a and not Rab23 seems to be necessary for polycystin-2 
to reach the ciliary membrane compartment, so obviously dif-
ferent monomeric G proteins regulate distinct intracellular traf-
ficking routes. Consistent with the importance of Rab8a is 
the observation that the synthesis of dominant-negative Rab8 in 
Xenopus laevis leads to retinal degeneration (Moritz et al., 2001). 
Retinal photoreceptor cells contain a structure called the con-
necting cilium, which is related to the primary cilium and which 
mediates the transport of proteins (such as rhodopsin) from the 
cell body of the photoreceptor cells to their outer segments. Our 
attempts to localize transport vesicles with polycystin-2 at the 
base of the cilium using -tubulin as a marker were not success-
ful (Fig. S4), but that could be due to the fact that -tubulin does 
not mark the docking station for those vesicles.
Neither in our current study nor in previous publications 
(Cai et al., 1999; Hidaka et al., 2004) was any evidence for   
the trafficking of full-length polycystin-2 through the Golgi   
Figure 9.  Rab8a is necessary for the trafficking of polycystin-2 into the 
primary cilium. Stably transfected LLC-PK1 cells inducibly synthesizing a 
fusion protein between EGFP and polycystin-2 (1–703) were microinjected 
with an expression plasmid encoding a fusion protein between RFP and 
the dominant-negative Rab8a T22N mutant protein. The cell marked by an 
asterisk synthesizes both Rab8a T22N (a) and polycystin-2 (1–703) (b), 
but its primary cilium (c and d, arrowhead) does not contain polycystin-2 
(1–703). In other cells not synthesizing Rab8a T22N, the primary cilium is 
positive for polycystin-2 (1–703) (b–d, arrow). Bar, 20 µm.JCB • VOLUME 192 • NUMBER 4 • 2011   642
(White et al., 2001) and TGN38 (McNamara et al., 2004), respectively. 
All constructs were sequence verified to ensure the absence of any un-
wanted mutations.
Transfections and cell culture
Stably transfected LtTA-2,22 cells (LLC-PK1 cells expressing the tetracycline-
dependent transactivator) inducibly producing the HA epitope–tagged 
full-length and (1–703) mutant polycystin-2 proteins have been described 
previously (Gallagher et al., 2006). HtTA-1 cells (HeLa cells expressing 
the tetracycline-dependent transactivator; Gossen and Bujard, 1992) were 
transfected with 8 µg of the expression plasmids pUHD 10–3/PKD2, HA 
and pUHD 10–3/PKD2 (1–703), HA, respectively, together with 0.8 µg 
of  the  selection  plasmid  pBabe  Puro  (Morgenstern  and  Land,  1990)   
by using a calcium phosphate protocol (Chen and Okayama, 1987). 
COS-7  and  LLC-PK1  cells  were  transiently  transfected  using  DEAE   
dextran/chloroquine  (Ausubel  et  al.,  1996),  poly-l-ornithine  (Dong  et  al., 
1993),  and  Lipofectamine  (Invitrogen),  respectively.  When  cells  were 
used for immunofluorescence, they were transferred onto coverslips 1 d 
after transfection.
mycophenolic acid incubation probably prevented the fast disso-
ciation of polycystin-2 from the cis-Golgi apparatus and resulted   
in its accumulation to high enough levels for it to be detectable 
by immunofluorescence.
We propose the following model as an attempt to combine 
the data available so far (Fig. 10). Polycystin-2 is constantly 
released in a COPII-dependent fashion from the ER to the Golgi 
apparatus but is immediately returned through the action of the 
retrieval signal in its C terminus (we favor this name over the 
term retention signal). Only a small portion of polycystin-2 will 
be able to escape from the retrograde transport to the ER and 
is transported further from the cis-Golgi apparatus to the pri-
mary cilium. The route of an integral membrane protein via the 
cis-Golgi compartment, i.e., without traversing the Golgi ap-
paratus, to the primary cilium probably is not restricted to poly-
cystin-2 because we also found no evidence that the M2 mutant 
of Smoothened traffics through the Golgi apparatus. In cells in 
which the retrieval signal of polycystin-2 is masked, as may be 
the case in the presence of polycystin-1 (Hanaoka et al., 2000), 
or lost as in C-terminally truncated polycystin-2 proteins, poly-
cystin-2 moves further through the Golgi apparatus and reaches 
the somatic plasma membrane. For this step the presence of a 
positive signal, such as the newly identified export motif repre-
sented by K572 and F576, is necessary. We also want to point 
out that mutations in the PKD2 gene have been described that 
lead to a frame shift after codon 566 (Viribay et al., 1997) and a 
truncation after codon 584 (Torra et al., 1999). Our results pre-
dict different intracellular locations for the two mutant proteins 
but it is not known whether these mutations result in different 
phenotypes. The presence of the full-length polycystin-2 pro-
tein in the plasma membrane is still discussed controversially. 
We propose that under various (patho)physiological conditions 
the KLFKFI motif modulates the transport of polycystin-2 to 
the somatic plasma membrane. In the case that the physiologi-
cal location of full-length polycystin-2 is the ER and the pri-
mary cilium (and not the somatic plasma membrane), then the 
KLFKFI motif could be a potential therapeutic target in order to 
impede the misdirected trafficking of mutant polycystin-2 pro-
teins to the somatic plasma membrane where they may lead to 
poorly controlled Ca
2+ currents.
Materials and methods
Expression plasmids
The constructs encoding HA epitope–tagged human full-length polycystin-2 
and  polycystin-2  (1–703)  proteins  have  been  described  previously   
(Gallagher et al., 2006). A fusion protein between EGFP and full-length 
polycystin-2 was created by inserting EGFP after amino acid 157 of poly-
cystin-2. Further polycystin-2 mutant proteins were engineered in the con-
text  of  the  mammalian  expression  plasmids  pcDNA3  (Invitrogen)  and 
pEGFP (Takara Bio Inc.). For ReAsH labeling, expression plasmids were 
generated that encoded fusion proteins between the respective polycystin-2 
proteins, the HA epitope, a tetracysteine motif, and EGFP. To produce fu-
sion proteins between ECFP and PIGEA-14 mutant proteins, the respective 
sequences of the PIGEA-14 cDNA were amplified by PCR and subcloned 
into pECFP. The constructs coding for fusion proteins of ECFP with the Sar1 
H79G and Sar1 T39N mutant proteins (Aridor et al., 1995) and the 
Rab23 S23N mutant protein (Guo et al., 2006) were generated by ampli-
fying the inserts by PCR and cloning them into pECFP (Takara Bio Inc.). The 
Golgi apparatus and trans-Golgi network were visualized in live cells through 
fusion  proteins  between  ECFP  and  N-acetylgalactosaminyltransferase-2 
Figure 10.  Model for the trafficking of polycystin-2 to the primary cilium. 
Most of the wild-type polycystin-2 protein leaves the ER in a COPII- 
dependent fashion and is rapidly returned from the Golgi apparatus due to the 
presence of a 34–amino acid retrieval signal in its C terminus (dark blue 
arrows). A small portion of wild-type polycystin-2 will reach the cis-Golgi 
apparatus (red arrow) and is diverted to the primary cilium (orange arrow), 
where the delivery is controlled by Rab8a. Whether the ciliary target-
ing signal “RVxP” in the N terminus of polycystin-2 acts at the cis-Golgi 
compartment or at a more distal location is not known. Under some circum-
stances, e.g., due to the interaction between polycystin-2 and polycystin-1 
or upon the loss of the retrieval signal in the C terminus, polycystin-2 will 
also reach the somatic plasma membrane through the Golgi apparatus 
(light blue arrow). Passage through the Golgi apparatus depends on the 
“KxxxF” motif in loop 4.643 Intracellular trafficking of polycystin-2 • Hoffmeister et al.
diluted  1:600;  Invitrogen),  Alexa  488–conjugated  goat  anti–mouse 
IgG (cat. no. A11029; diluted 1:600; Invitrogen), Alexa 633–conjugated 
goat anti–rabbit IgG (cat. no. A21071; diluted 1:600; Invitrogen), and   
Alexa 633–conjugated goat anti–mouse IgG (cat. no. A21052; diluted 
1:600; Invitrogen).
ReAsH labeling and electron microscopy
COS-7 cells were transiently transfected using DEAE dextran/chloroquine 
(Ausubel et al., 1996). 3 d later, the cells were washed three times with 
HBSS. After they were incubated for 1 h at 37°C with 450 nM ReAsH 
(resorufin arsenical hairpin binding reagent; Invitrogen), 12.5 µM EDT 
(1,2-ethanedithiol; Fluka), the cells were washed twice briefly with 500 nM 
BAL (2,3-dimercapto-1-propanol; Fluka) and then were incubated in 500 nM 
BAL for 20 min at 37°C, washed again three times with HBSS, and fixed 
with 2% glutaraldehyde overnight. Once the fixed cells were blocked for 
30 min in 50 mM glycine, 10 mM KCN, 20 mM aminotriazole, 0.001% 
H2O2 and washed, a new buffer containing 1 mg/ml of diaminobenzidine 
was added. Photoconversion was performed by exposing the cells at 4°C 
to a 585-nm light source. Finally the cells were washed again and em-
bedded in Durcupan (Fluka). 50-nm thin sections were analyzed in a transmis-
sion  electron  microscope  (EM  902;  Carl  Zeiss,  Inc.)  equipped  with  a 
cooled CCD digital camera (TRS).
Metabolic labeling and immunoprecipitation
Cells were cultured in 100-mm Petri dishes and grown to 70% conflu-
ency. Then cells were washed twice with cysteine/methionine-free DME 
containing 2 mM l-glutamine and 5% dialyzed fetal calf serum before 
being preincubated in this medium for 30 min at 37°C. The labeling was 
performed in 4 ml fresh medium with 250 µCi Tran
35S-Label (MP Biomedicals) 
for 5 min at 37°C (pulse). To terminate the pulse, the cells were washed 
twice with chase medium (complete DME with 10% FCS), and chased for 
different times as indicated. After metabolic labeling the cells were washed 
twice with ice-cold 1x PBS and lysed with RIPA buffer (1% Triton X-100, 1% 
sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 10 mM sodium phos-
phate, pH 7.2, 2 mM EDTA, pH 8.0, 50 mM NaF, 0.2 mM NaVO3, 3 µg/ml 
of leupeptin, and 10 µg/ml of aprotinin). The lysate was transferred to a 
1.5-ml microcentrifuge tube, passed multiple times through a needle to re-
duce its viscosity, and then centrifuged for 5 min at 14,000 rpm to remove 
insoluble material. For immunoprecipitation, 500 µl of radiolabeled cell ly-
sate were incubated for 90 min at 4°C with 50 µl of supernatant from the 
12CA5  hybridoma,  which  produces  mouse  monoclonal  antibodies  di-
rected against the HA epitope. Then 25 µl of swollen protein A–Sepharose 
beads were added to precipitate the immune complexes, followed by fur-
ther incubation for 90 min at 4°C. Subsequently, the beads were washed 
twice in the appropriate lysis buffer, resuspended in 50 µl of 1x SDS sam-
ple buffer (125 mM Tris-HCl, pH 6.7, 2.5% SDS, 10% glycerol, 2.5%   
-mercaptoethanol, and 0.01% bromophenol blue), and incubated on ice 
for 30 min to elute the precipitated proteins from the beads.
SDS-PAGE and Western blotting
For immunodetection, proteins were separated on denaturing polyacryl-
amide gels without prior boiling and then electrophoretically transferred 
onto a polyvinylidene difluoride (PVDF) membrane (Millipore). After trans-
fer, the membrane was blocked overnight at room temperature in 1x PBS, 
5% low-fat dry milk powder, 0.2% Tween 20, and then incubated for 1 h 
with the primary antibody. The following primary antibodies were used: 
the rat monoclonal anti-HA-epitope antibody 3F10 (cat. no. 11 867 423 
001; diluted 1:4,000; Roche) and the mouse monoclonal anti-Na
+/K
+-
ATPase 1-subunit (cat. no. A-277; diluted 1:3,000; Sigma-Aldrich).   
After washes with 1x PBS, 0.2% Tween 20, the membrane was incubated 
for 1 h with the HRP-conjugated goat anti–rat IgG secondary antibody 
(cat.  no.  112–035-068;  diluted  1:20,000;  Jackson  ImmunoResearch 
Laboratories) and HRP-conjugated goat anti–mouse IgG (cat. no. A3682; 
diluted 1:10,000; Sigma-Aldrich). To detect the secondary antibodies, a 
chemiluminescence detection kit (PerkinElmer) was used. For the detection 
of 
35S-labeled proteins, the gels were dried and exposed to RX NIF x-ray 
film (Fujifilm).
Glycosidase treatment
Glycosidase treatment was essentially performed according to the manu-
facturer’s instructions (New England Biolabs, Inc.). In the case of 
35S-labeled 
polycystin-2, the beads with the immunoprecipitated protein were resuspended 
in 50 µl buffer containing 2% -mercaptoethanol, 1% SDS, 100 mM Tris,   
pH 7.5 before the samples were incubated for 1 h at 37°C with 1,000 U   
endoglycosidase  Hf  (Endo  H)  or  1,000  U  peptide:N-glycosidase  F 
(PNGase F). The reactions were terminated by the addition of 25 µl 3x SDS 
For the brefeldin A studies, the stably transfected LtTA-2,22 cells 
were plated onto coverslips. When the cells had reached 100% conflu-
ency, brefeldin A (Fluka) was added to the medium at a concentration of 
0.5 µg/ml; the solvent methanol served as a negative control. In the case 
of the LtTA-2,22 cells producing full-length polycystin-2, brefeldin A was 
applied when the cells were induced; in the case of the LtTA-2,22 cells pro-
ducing the polycystin-2 (1–703) protein, brefeldin A was added 24 h after 
the cells were induced. 48 h after treatment with brefeldin A the cells were 
subjected to immunofluorescence. For the mycophenolic acid experiments, 
stably transfected cells producing HA epitope–tagged full-length polycystin-2 
were incubated for 6 h with 50 µM of mycophenolic acid. Mycophenolic 
acid was dissolved in ethanol and cells incubated with 0.2% of ethanol 
therefore served as a negative control. After the incubation, cells were 
fixed and stained for the HA epitope and the cis-Golgi marker GM130.
Live-cell imaging was performed in LtTA-2,22 cells stably transfected 
with expression plasmids for fusion proteins between ECFP and the Golgi 
marker enzyme N-acetylgalactosaminyltransferase-2 and the trans-Golgi 
marker protein TGN38, respectively. Individual clones were then transiently 
transfected with expression plasmids for fusion proteins between EGFP and 
polycystin-2 mutant proteins, and with expression plasmids for fusion pro-
teins between EYFP and Smoothened. For imaging analysis, cells were 
plated onto µ-dishes (ibidi). To enhance the signal, the cells were incubated 
for 5 h at 15°C to block protein transport between the ER and the Golgi 
apparatus. After transferring the cells to Krebs-Henseleit buffer prewarmed 
to 37°C, pictures were taken every 2 min. Alternatively, cells were fixed 
immediately after the 15°C block as well as after 15 and 40 min of incuba-
tion at 37°C. The imaging setup consisted of an inverted microscope (Ob-
server Z1; Carl Zeiss, Inc.) equipped with a c-Apochromat 63x/1.20w 
objective, a confocal laser scanning microscope (LSM 710; Carl Zeiss, 
Inc.) operated with the ZEN 2008 software, the polychromatic illumination 
system VisiChrome (Visitron), and the MetaMorph software package (Uni-
versal Imaging Corp.). Spectral unmixing was done on images taken with 
the built-in 34-channel detection unit of the laser scanning microscope and 
with an ImageJ (Abramoff et al., 2004) plug-in written by Joachim Walter. 
Further image processing was done using the Levels and Curves functions 
of Adobe Photoshop CS4.
To investigate the effect of PIGEA-14 mutant proteins, stably trans-
fected  LLC-PK1  cells  inducibly  producing  HA  epitope–tagged  full-length 
polycystin-2 and polycystin-2 (1–703) were transiently transfected with the 
pECFP/PIGEA-14 constructs. After 4 h of exposure to the lipofectamine/
DNA mixture, the cells were washed and medium without doxycycline was 
added. 3 d later, the cells were fixed and stained with antibodies against 
acetylated tubulin and the HA epitope.
Immunofluorescence
Cells were fixed in 1x PBS (10 mM potassium phosphate, pH 7.5, and 
140 mM NaCl), 4% paraformaldehyde for 1 h at room temperature, or in 
100% methanol for 6 min at 20°C. After three washes with 1x PBS, they 
were either permeabilized for 15 min in 1x PBS, 0.25% Triton X-100, or 
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clonal  anti–-tubulin  antibody  (cat.  no.  sc-51715;  diluted  1:50;  Santa 
Cruz Biotechnology, Inc.), a mouse monoclonal anti-GM130 antibody   
(cat. no. 610822; diluted 1:40; BD), and a rabbit polyclonal anti-Arl13b 
antibody (diluted 1:100; Duldulao et al., 2009). Specific staining was   
visualized with FITC-conjugated goat anti–mouse IgG (cat. no. 55493;   
diluted 1:200; MP Biomedicals), Cy3-conjugated goat anti–mouse IgG 
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sample buffer. After a further incubation for 15 min at 37°C the samples 
were loaded on a protein gel and analyzed by autoradiography. When 
nonlabeled polycystin-2 protein was analyzed, whole-cell lysate containing 
10–20 µg of protein was incubated for 90 min at 37°C with 1,000 U of 
endoglycosidase Hf.
Cell surface biotinylation
All steps were performed at 4°C. After cells were washed four times with 
1x PBS-CM (10 mM potassium phosphate, pH 7.5, 140 mM NaCl, 0.1 mM 
CaCl2, and 1 mM MgCl2), they were incubated for 30 min in the same 
buffer containing 0.5 mg/ml of EZ-Link Sulfo-NHS-SS-Biotin (Thermo Fisher 
Scientific). The biotinylation reaction was quenched by incubating for 20 min 
with 1x PBS-CM containing 100 mM glycine. Then the cells were rinsed 
four times with 50 mM Tris HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, pH 8.0 
and lysed in the same buffer supplemented with 1% Triton X-100. Whole-cell 
lysate corresponding to 130–170 µg of protein was immunoprecipitated 
overnight in a volume of 200 µl with 25 µl of NeutrAvidin beads (Thermo 
Fisher Scientific). After extensive washes with 50 mM Tris HCl, pH 7.5, 
150 mM NaCl, 5 mM EDTA, pH 8.0, and 50 mM Tris HCl, pH 7.5,   
500 mM NaCl, 5 mM EDTA, pH 8.0, the NeutrAvidin beads were resus-
pended in SDS sample buffer and subjected to Western blot analysis.
Microinjection
LtTA-2,22 cells were stably transfected with a tetracycline-inducible expres-
sion plasmid coding for a fusion protein between the HA epitope–tagged 
polycystin-2 (1–703) protein and EGFP. When needed, the cells were cul-
tured on coverslips until they reached confluency. Then expression was in-
duced and plasmids (500 ng/µl) were injected with the InjectMan/FemtoJet 
System (Eppendorf) on a microscope (Axiovert 200; Carl Zeiss, Inc.). After 
microinjection, the cells were incubated at 37°C until the fluorescence-
tagged protein was detected (typically up to 4 h). The injected plasmids 
coded for ECFP (Takara Bio Inc.), for a fusion protein between ECFP and 
amino acids 65–126 of PIGEA-14, for a fusion protein between mRFP and 
the dominant-negative Rab8a T22N mutant protein (Bravo-Cordero et al., 
2007), and for a fusion protein between ECFP and the dominant-negative 
Rab23 S23N mutant protein (Guo et al., 2006).
Online supplemental material
Fig. S1 shows that the polycystin-2 (1–703) protein is not present in cilia 
after BFA treatment, as demonstrated by staining for Arl13b. Fig. S2 shows 
the colocalization of full-length polycystin-2 and GM130 upon treatment 
with mycophenolic acid. Fig. S3 shows the effect of PIGEA-14 mutant pro-
teins on the ciliary trafficking of polycystin-2. Fig. S4 shows double stain-
ing for full-length polycystin-2 and -tubulin. Video 1 shows the imaging 
of full-length polycystin-2 and the Golgi marker N-acetylgalactosaminyl-
transferase-2. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201007050/DC1.
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